This has led researchers to discover that mutations in GBA1 are a genetic risk factor for synucleinopathies similar to Parkinson’s disease (PD) and DLB (Goker-Alpan et al., 2004; Lwin et al., 2004). The gene discussed is GBA1; the disease is Lewy body dementia.